Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126298631 | 12629863 | 1 | I | 20160728 | 20160808 | 20160808 | EXP | CA-SA-2016SA138607 | AVENTIS | 52.00 | YR | A | F | Y | 0.00000 | 20160808 | MD | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126298631 | 12629863 | 1 | PS | ARAVA | LEFLUNOMIDE | 1 | Unknown | N | UNKNOWN | 20905 | 20 | MG | QD | ||||||
126298631 | 12629863 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | N | UNKNOWN | 0 | |||||||||
126298631 | 12629863 | 3 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNKNOWN | 0 | 25 | MG | /wk | |||||||
126298631 | 12629863 | 4 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | N | UNKNOWN | 0 | |||||||||
126298631 | 12629863 | 5 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Unknown | U | UNKNOWN | 0 | TABLET | ||||||||
126298631 | 12629863 | 6 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | N | UNKNOWN | 0 | |||||||||
126298631 | 12629863 | 7 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Unknown | 0 | 400 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126298631 | 12629863 | 2 | Rheumatoid arthritis |
126298631 | 12629863 | 3 | Rheumatoid arthritis |
126298631 | 12629863 | 4 | Rheumatoid arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126298631 | 12629863 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126298631 | 12629863 | Cataract | |
126298631 | 12629863 | Drug effect incomplete | |
126298631 | 12629863 | Drug hypersensitivity | |
126298631 | 12629863 | Drug intolerance | |
126298631 | 12629863 | Hepatic enzyme increased | |
126298631 | 12629863 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126298631 | 12629863 | 2 | 2016 | 0 | ||
126298631 | 12629863 | 6 | 2016 | 0 | ||
126298631 | 12629863 | 7 | 2016 | 0 |